Accelrys Posts 12 Percent Revenue Gain for Q3 | GenomeWeb

NEW YORK (GenomeWeb News) – Accelrys reported after the close of the market yesterday a 12 percent increase year over year for its third quarter.

The San Diego-based life sciences informatics firm reported GAAP revenues of $40.5 million for the three months ended Sept. 30, compared to $36.3 million for the third quarter of 2011.

Its non-GAAP revenue, which includes a deferred revenue fair value adjustment related to its merger with Symyx and acquisitions of Contur and VelQuest, was $43.4 million versus 38 million, a 14 percent increase.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: effect of variants linked to body shape differs by age and sex, transcriptome differences in bats with and without white-nose syndrome, and more.

A researcher argues that big prizes like the Nobel or Lasker awards send the wrong message about research.

Maria Freire, the president of the Foundation for the National Institutes of Health, discusses recent genomics-fueled advances with The Open Mind's Alexander Heffner.

Three researchers win the Nobel Prize for their efforts to develop treatments for parasitic diseases.

Sponsored by
Oracle Health Sciences

Brian Wells of Penn Medicine will detail how his team's "PennOmics" integrated healthcare data warehouse accelerates clinical trial recruitment at the point of care, accepts data from wearables, and does it all in a secure, HIPAA- and research-compliant fashion.